Effect of levamisole on bacterial index in BL and LL leprosy

A 150 mg levamisole tablet once in every fortnight along with specific antileprosy drugs were administered to ten patients each in BL and LL groups of leprosy. A similar number of patients in each group receiving only specific antileprosy treatment served as controls. After 11/2 years of study a more significant improvement was noted in the bacteriological status in the levamisole-treated group. Thus, levamisole can be used as an effective adjunct for quicker recovery in lepromatous patients.